174 related articles for article (PubMed ID: 24337215)
1. The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes.
Kengne AP
Cardiovasc J Afr; 2013; 24(9-10):376-81. PubMed ID: 24337215
[TBL] [Abstract][Full Text] [Related]
2. On the importance of global cardiovascular risk assessment in people with type 2 diabetes.
Echouffo-Tcheugui JB; Kengne AP
Prim Care Diabetes; 2013 Jul; 7(2):95-102. PubMed ID: 23623209
[TBL] [Abstract][Full Text] [Related]
3. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
[TBL] [Abstract][Full Text] [Related]
4. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
Echouffo-Tcheugui JB; Kengne AP
Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
[TBL] [Abstract][Full Text] [Related]
5. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
7. New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort.
Robinson T; Elley CR; Wells S; Robinson E; Kenealy T; Pylypchuk R; Bramley D; Arroll B; Crengle S; Riddell T; Ameratunga S; Metcalf P; Drury PL
J Prim Health Care; 2012 Sep; 4(3):181-8. PubMed ID: 22946065
[TBL] [Abstract][Full Text] [Related]
8. Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of cohort studies.
Zhao Y; Qie R; Han M; Huang S; Wu X; Zhang Y; Feng Y; Yang X; Li Y; Wu Y; Liu D; Hu F; Zhang M; Sun L; Hu D
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):1976-1984. PubMed ID: 33965298
[TBL] [Abstract][Full Text] [Related]
9. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
[TBL] [Abstract][Full Text] [Related]
10. The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes Complications; 2012; 26(3):187-94. PubMed ID: 22521319
[TBL] [Abstract][Full Text] [Related]
11. Prognostic tools for cardiovascular disease in patients with type 2 diabetes: A systematic review and meta-analysis of C-statistics.
Chowdhury MZI; Yeasmin F; Rabi DM; Ronksley PE; Turin TC
J Diabetes Complications; 2019 Jan; 33(1):98-111. PubMed ID: 30446478
[TBL] [Abstract][Full Text] [Related]
12. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus.
Prausmüller S; Resl M; Arfsten H; Spinka G; Wurm R; Neuhold S; Bartko PE; Goliasch G; Strunk G; Pavo N; Clodi M; Hülsmann M
Cardiovasc Diabetol; 2021 Feb; 20(1):34. PubMed ID: 33530999
[TBL] [Abstract][Full Text] [Related]
13. Diet Quality and Cardiovascular Disease Risk in Postmenopausal Women With Type 2 Diabetes Mellitus: The Women's Health Initiative.
Hirahatake KM; Jiang L; Wong ND; Shikany JM; Eaton CB; Allison MA; Martin L; Garcia L; Zaslavsky O; Odegaard AO
J Am Heart Assoc; 2019 Oct; 8(19):e013249. PubMed ID: 31533514
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
15. Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
Østergaard HB; Hageman SHJ; Read SH; Taylor O; Pennells L; Kaptoge S; Petitjean C; Xu Z; Shi F; McEvoy JW; Herrington W; Visseren FLJ; Wood A; Eliasson B; Sattar N; Wild S; Di Angelantonio E; Dorresteijn JAN
Eur J Prev Cardiol; 2023 Jan; 30(1):61-69. PubMed ID: 36208182
[TBL] [Abstract][Full Text] [Related]
16. Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS.
Choi Y; Choi JW
Cardiovasc Diabetol; 2020 May; 19(1):61. PubMed ID: 32404104
[TBL] [Abstract][Full Text] [Related]
17. Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.
Strelitz J; Ahern AL; Long GH; Boothby CE; Wareham NJ; Griffin SJ
Cardiovasc Diabetol; 2019 Aug; 18(1):98. PubMed ID: 31370851
[TBL] [Abstract][Full Text] [Related]
18. Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.
Price HC; Coleman RL; Stevens RJ; Holman RR
Diabetologia; 2009 Mar; 52(3):394-7. PubMed ID: 19048226
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
Herath HM; Weerarathna TP; Umesha D
Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
[TBL] [Abstract][Full Text] [Related]
20. Overview of Risk-Estimation Tools for Primary Prevention of Cardiovascular Diseases in European Populations.
Gorenoi V; Hagen A
Cent Eur J Public Health; 2015 Jun; 23(2):91-9. PubMed ID: 26851417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
